Randomized phase II study of the induction chemotherapy with docetaxel alone vs CDDP [cisplatin] + docetaxel for c-stage IB-II non-small lung cancer (JCOG 0204-MF).

Trial Profile

Randomized phase II study of the induction chemotherapy with docetaxel alone vs CDDP [cisplatin] + docetaxel for c-stage IB-II non-small lung cancer (JCOG 0204-MF).

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Docetaxel (Primary) ; Cisplatin
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2010 5-year results presented at 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
    • 14 Aug 2009 New source identified and integrated (University Hospital Medical Information Network - Japan).
    • 09 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top